Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 19272 | 9.7083 |
09:34 ET | 300 | 9.58 |
09:36 ET | 600 | 9.52 |
09:38 ET | 200 | 9.52 |
09:39 ET | 1896 | 9.5 |
09:41 ET | 1096 | 9.52 |
09:43 ET | 2938 | 9.5 |
09:45 ET | 2620 | 9.5 |
09:48 ET | 200 | 9.505 |
09:50 ET | 1602 | 9.49 |
09:52 ET | 3217 | 9.54 |
09:54 ET | 499 | 9.56 |
09:56 ET | 1722 | 9.58 |
09:57 ET | 800 | 9.6 |
09:59 ET | 600 | 9.575 |
10:01 ET | 2266 | 9.55 |
10:03 ET | 1200 | 9.57 |
10:06 ET | 1196 | 9.6 |
10:08 ET | 300 | 9.58 |
10:10 ET | 1321 | 9.59 |
10:12 ET | 300 | 9.57 |
10:14 ET | 536 | 9.57 |
10:15 ET | 500 | 9.58 |
10:17 ET | 626 | 9.57 |
10:19 ET | 1683 | 9.535 |
10:21 ET | 1000 | 9.51 |
10:24 ET | 1012 | 9.525 |
10:26 ET | 200 | 9.5 |
10:28 ET | 2100 | 9.495 |
10:30 ET | 3769 | 9.49 |
10:32 ET | 800 | 9.445 |
10:33 ET | 900 | 9.45 |
10:37 ET | 700 | 9.425 |
10:39 ET | 2642 | 9.425 |
10:42 ET | 1113 | 9.41 |
10:44 ET | 2300 | 9.4 |
10:46 ET | 1888 | 9.39 |
10:48 ET | 1772 | 9.385 |
10:50 ET | 600 | 9.38 |
10:51 ET | 1870 | 9.396 |
10:53 ET | 1848 | 9.39 |
10:55 ET | 450 | 9.36 |
10:57 ET | 300 | 9.38 |
11:00 ET | 800 | 9.395 |
11:02 ET | 400 | 9.4 |
11:04 ET | 900 | 9.405 |
11:06 ET | 711 | 9.4 |
11:09 ET | 100 | 9.41 |
11:11 ET | 500 | 9.41 |
11:13 ET | 500 | 9.42 |
11:15 ET | 200 | 9.425 |
11:18 ET | 1000 | 9.425 |
11:20 ET | 499 | 9.42 |
11:22 ET | 409 | 9.45 |
11:26 ET | 840 | 9.46 |
11:27 ET | 100 | 9.46 |
11:29 ET | 600 | 9.46 |
11:31 ET | 469 | 9.465 |
11:33 ET | 726 | 9.455 |
11:38 ET | 2303 | 9.435 |
11:40 ET | 800 | 9.46 |
11:42 ET | 994 | 9.47 |
11:44 ET | 600 | 9.46 |
11:45 ET | 1203 | 9.47 |
11:47 ET | 634 | 9.47 |
11:49 ET | 1000 | 9.465 |
11:51 ET | 820 | 9.47 |
11:54 ET | 500 | 9.47 |
11:56 ET | 299 | 9.46 |
11:58 ET | 2252 | 9.4575 |
12:00 ET | 413 | 9.475 |
12:02 ET | 2213 | 9.475 |
12:03 ET | 1037 | 9.455 |
12:05 ET | 707 | 9.445 |
12:07 ET | 800 | 9.43 |
12:09 ET | 2194 | 9.455 |
12:12 ET | 468 | 9.47 |
12:14 ET | 1086 | 9.455 |
12:16 ET | 400 | 9.46 |
12:18 ET | 900 | 9.455 |
12:20 ET | 2678 | 9.435 |
12:21 ET | 625 | 9.45 |
12:23 ET | 500 | 9.45 |
12:25 ET | 200 | 9.445 |
12:27 ET | 4766 | 9.45 |
12:30 ET | 2965 | 9.41 |
12:32 ET | 486 | 9.41 |
12:34 ET | 400 | 9.41 |
12:36 ET | 200 | 9.41 |
12:38 ET | 300 | 9.405 |
12:39 ET | 600 | 9.41 |
12:41 ET | 200 | 9.42 |
12:43 ET | 400 | 9.405 |
12:45 ET | 100 | 9.41 |
12:48 ET | 1157 | 9.38 |
12:50 ET | 760 | 9.41 |
12:52 ET | 400 | 9.41 |
12:54 ET | 300 | 9.41 |
12:57 ET | 1173 | 9.405 |
12:59 ET | 300 | 9.4 |
01:01 ET | 200 | 9.405 |
01:03 ET | 900 | 9.405 |
01:06 ET | 800 | 9.39 |
01:08 ET | 2051 | 9.39 |
01:10 ET | 200 | 9.395 |
01:12 ET | 408 | 9.39 |
01:14 ET | 500 | 9.39 |
01:15 ET | 991 | 9.405 |
01:17 ET | 600 | 9.395 |
01:19 ET | 803 | 9.39 |
01:21 ET | 2310 | 9.37 |
01:24 ET | 200 | 9.36 |
01:26 ET | 997 | 9.38 |
01:28 ET | 1125 | 9.38 |
01:30 ET | 200 | 9.385 |
01:32 ET | 12499 | 9.39 |
01:33 ET | 981 | 9.41 |
01:35 ET | 400 | 9.41 |
01:37 ET | 929 | 9.42 |
01:39 ET | 776 | 9.42 |
01:42 ET | 1300 | 9.4 |
01:44 ET | 100 | 9.39 |
01:46 ET | 900 | 9.405 |
01:48 ET | 788 | 9.39 |
01:51 ET | 1100 | 9.41 |
01:53 ET | 1568 | 9.4 |
01:55 ET | 200 | 9.395 |
01:57 ET | 911 | 9.4 |
02:00 ET | 1150 | 9.39 |
02:02 ET | 100 | 9.39 |
02:04 ET | 368 | 9.38 |
02:06 ET | 600 | 9.375 |
02:08 ET | 218 | 9.38 |
02:09 ET | 512 | 9.38 |
02:11 ET | 300 | 9.39 |
02:13 ET | 300 | 9.4 |
02:15 ET | 2192 | 9.39 |
02:18 ET | 500 | 9.39 |
02:20 ET | 1100 | 9.4 |
02:22 ET | 100 | 9.395 |
02:24 ET | 600 | 9.385 |
02:26 ET | 1024 | 9.37 |
02:27 ET | 1239 | 9.37 |
02:29 ET | 1200 | 9.365 |
02:31 ET | 1124 | 9.37 |
02:33 ET | 500 | 9.375 |
02:36 ET | 400 | 9.38 |
02:38 ET | 600 | 9.39 |
02:40 ET | 729 | 9.4 |
02:42 ET | 542 | 9.41 |
02:44 ET | 700 | 9.43 |
02:45 ET | 2193 | 9.425 |
02:47 ET | 1900 | 9.405 |
02:49 ET | 300 | 9.41 |
02:51 ET | 485 | 9.405 |
02:54 ET | 1435 | 9.42 |
02:56 ET | 1216 | 9.4 |
02:58 ET | 1360 | 9.39 |
03:00 ET | 1212 | 9.385 |
03:02 ET | 1255 | 9.39 |
03:03 ET | 1800 | 9.39 |
03:05 ET | 200 | 9.395 |
03:07 ET | 2331 | 9.39 |
03:09 ET | 432 | 9.38 |
03:12 ET | 300 | 9.38 |
03:14 ET | 300 | 9.385 |
03:16 ET | 2979 | 9.39 |
03:18 ET | 927 | 9.385 |
03:20 ET | 300 | 9.39 |
03:21 ET | 400 | 9.385 |
03:23 ET | 1627 | 9.385 |
03:25 ET | 100 | 9.385 |
03:27 ET | 1499 | 9.38 |
03:30 ET | 200 | 9.385 |
03:32 ET | 1934 | 9.4 |
03:34 ET | 1640 | 9.405 |
03:36 ET | 1600 | 9.395 |
03:38 ET | 500 | 9.4 |
03:39 ET | 300 | 9.41 |
03:41 ET | 2947 | 9.395 |
03:43 ET | 900 | 9.38 |
03:45 ET | 1072 | 9.39 |
03:48 ET | 2581 | 9.395 |
03:50 ET | 2066 | 9.39 |
03:52 ET | 4962 | 9.37 |
03:54 ET | 2174 | 9.38 |
03:56 ET | 12992 | 9.415 |
03:57 ET | 16988 | 9.45 |
03:59 ET | 157315 | 9.44 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.3B | -2.4x | --- |
Prothena Corporation PLC | 1.1B | -6.6x | --- |
Immatics NV | 1.1B | -8.4x | --- |
Silence Therapeutics PLC | 986.3M | -14.3x | --- |
Arcus Biosciences Inc | 1.5B | -5.4x | --- |
4D Molecular Therapeutics Inc | 1.3B | -10.0x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 16.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.